Álvaro Aceña - Concepedia

Author

Álvaro Aceña

Hospital Universitario Fundación Jiménez Díaz ORCID

Also Known As

A A Acena, A Acena, A. Acena, A. Aceña, A. Gómez Aceña, Alicia Moreno, Alvaro Acena, Alvaro Aceña, lvaro Acea, Á. Aceña

Publications

983

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Fundación Jiménez Díaz Universidad Autónoma de Madrid Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas Hospital Universitario de Móstoles Hospital Universitario Fundación Alcorcón

ÁA

About

Álvaro Aceña is an author at Hospital Universitario Fundación Jiménez Díaz specializing in cardiovascular disease, medicine, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	5	317
2	Health Sciences	2	2	36
3	Public Health	1	1	17
4	Emergency Medicine	1	2	264
5	Epidemiology	1	1	17

Álvaro Aceña

Publications

661

Citations

H-Index

Page 1

	Year	Citations
Short- and Long-Term Prognostic Relevance of Cardiogenic Shock in Takotsubo Syndrome Manuel Almendro‐Delia, Iván J. Núñez‐Gil, Manuel Lobo, JACC Heart Failure Heart FailureCardiogenic ShockCardiovascular DiseaseLong-term Prognostic RelevanceTakotsubo Syndrome	2018	132
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm Steven H J Hageman, Ailsa McKay, Peter Ueda, European Heart Journal	2022	105
Prevalence of Transthyretin Amyloidosis in Patients with Heart Failure and No Left Ventricular Hypertrophy Ana Devesa, Andrea Camblor Blasco, A. M. Lázaro, ESC Heart Failure	2021	55
Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease José Tuñón, Carmen Cristóbal, Nieves Tarín, PLoS ONE	2014	50
MCP-1 Predicts Recurrent Cardiovascular Events in Patients with Persistent Inflammation Luis Miguel Blanco‐Colio, Nerea Méndez‐Barbero, A. M. Lázaro, Journal of Clinical Medicine	2021	37
Circulating fibroblast growth factor‐23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease José Tuñón, Beatriz Fernández‐Fernández, Rocío Carda, Diabetes/Metabolism Research and Reviews	2016	36
First and Second Waves of Coronavirus Disease 2019 in Madrid, Spain: Clinical Characteristics and Hematological Risk Factors Associated With Critical/Fatal Illness Irene Mollinedo-Gajate, Felipe Villar Álvarez, María de los Ángeles Zambrano-Chacón, Critical Care Explorations	2021	32
Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease A. M. Lázaro, Carmen Cristóbal, Juan Antonio Franco Peláez, PLoS ONE	2017	28
Galectin-3 is Associated with Cardiovascular Events in Post-Acute Coronary Syndrome Patients with Type-2 Diabetes Ana Lorenzo-Almorós, Ana María Pello, Álvaro Aceña, Journal of Clinical Medicine	2020	24
The Prognostic Value of High-Sensitive Troponin I in Stable Coronary Artery Disease Depends on Age and Other Clinical Variables Rocío Carda, Álvaro Aceña, Ana María Pello, Cardiology	2015	20

Page 1